NCT02681679View on ClinicalTrials.gov

Topical 0.1% Bromfenac Sodium and Prostaglandin E2 Inhibition in Cataract Surgery

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions
Cataract
Interventions
DRUG

0.1% bromfenac ophthalmic solution

PROCEDURE

femtosecond laser cataract surgery

Trial Locations (1)

510060

Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou

All Listed Sponsors
collaborator

Ministry of Health, China

OTHER_GOV

lead

Sun Yat-sen University

OTHER

NCT02681679 - Topical 0.1% Bromfenac Sodium and Prostaglandin E2 Inhibition in Cataract Surgery | Biotech Hunter | Biotech Hunter